Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells. - Wikidata - awgldk - TriplyDB

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

http://www.wikidata.org/entity/Q33855405

about

Gene therapy for carcinoma of the breast: Genetic immunotherapy Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial Sustained expansion of NKT cells and antigen-specific T cells after injection of alpha-galactosyl-ceramide loaded mature dendritic cells in cancer patients.The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease Primer on tumor immunology and cancer immunotherapy Targeted Delivery of Small Interfering RNA to Human Dendritic Cells To Suppress Dengue Virus Infection and Associated Proinflammatory Cytokine Production Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.Immunosuppressive networks in the tumour environment and their therapeutic relevance Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo Twelve-year survival and immune correlates in dendritic cell-vaccinated melanoma patients.Targeting a mimotope vaccine to activating Fcgamma receptors empowers dendritic cells to prime specific CD8+ T cell responses in tumor-bearing mice.A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy CD40-activated B cells induce anti-tumor immunity in vivo.HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other The decreased replicative capacity of simian immunodeficiency virus SIVmac239Delta(nef) is manifest in cultures of immature dendritic cellsand T cells.Processing and presentation of exogenous HLA class I peptides by dendritic cells from human immunodeficiency virus type 1-infected persons.Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling.Adeno-associated virus type 2-mediated transduction of human monocyte-derived dendritic cells: implications for ex vivo immunotherapy.Mature dendritic cells infected with canarypox virus elicit strong anti-human immunodeficiency virus CD8+ and CD4+ T-cell responses from chronically infected individuals.Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance.Remnants of suicidal cells fostering systemic autoaggression. Apoptosis in the origin and maintenance of autoimmunity.Expression of ICAM-1, HLA-DR, and CD80 on peripheral circulating CD1 alpha DCs induced in vivo by IFN-alpha in patients with chronic hepatitis B Humoral and cell-mediated adaptive immune responses are required for protection against Burkholderia pseudomallei challenge and bacterial clearance postinfection.Dendritic cells and immunotherapy for malignant disease.Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.Increased macrophage infection upon subcutaneous inoculation of rhesus macaques with simian immunodeficiency virus-loaded dendritic cells or T cells but not with cell-free virus.Concurrent interaction of DCs with CD4(+) and CD8(+) T cells improves secondary CTL expansion: It takes three to tango.Biological and clinical developments in melanoma vaccines.CXCL12/CXCR4 blockade by oncolytic virotherapy inhibits ovarian cancer growth by decreasing immunosuppression and targeting cancer-initiating cells.TNF-α and tumor lysate promote the maturation of dendritic cells for immunotherapy for advanced malignant bone and soft tissue tumors.Development and use of multimeric major histocompatibility complex molecules.Strategies for designing and optimizing new generation vaccines.Effect of ex vivo culture duration on phenotype and cytokine production by mature dendritic cells derived from peripheral blood monocytes Cellular immunotherapy after autologous hematopoietic stem cell transplantation: experimental strategies and clinical experiences.Microbial stimulation fully differentiates monocytes to DC-SIGN/CD209(+) dendritic cells for immune T cell areas.Efficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route.Distinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.Development of new strategies to prevent type 1 diabetes: the role of animal models.An effective cancer vaccine modality: lentiviral modification of dendritic cells expressing multiple cancer-specific antigens Phenotype and in vitro function of mature MDDC generated from cryopreserved PBMC of cancer patients are equivalent to those from healthy donors.

P2860

Q24797848-050776D7-A612-4A3C-9CFC-126D1C2A2C24 Q24801506-1B18C3B8-3B3E-451D-8638-424DA2796769 Q25255724-0376B569-1CCD-4A73-B25E-81A4C601E13A Q26784452-74174F8D-5946-4521-9F46-678FADC38FCC Q27001126-25867EE0-17B6-4CF4-BC29-994177B99A00 Q27490919-6B09B717-E63D-4691-ACCA-EC99665FE9A0 Q28744503-DE6EBF97-5398-48CC-850C-8F1C9779C294 Q29619244-1A9BD745-CAF2-4AF9-9009-753719759C4B Q30080006-8124545C-70A2-40B8-BFAE-F6224A0D0603 Q30846001-397F705D-FE18-414A-BC9F-8068D951DDD3 Q33584637-0EC3711E-3D90-42B0-9C59-F199BD1141D7 Q33645564-3A45A0E0-0B8C-4A92-8348-35A5FAD46589 Q33709425-9D38F86B-0278-4789-A67F-F41531361824 Q33787144-ACAF6906-B711-43B2-B0DF-A7E37B3A2962 Q33799165-8BB7A412-551F-4DE0-A92C-66EF0A541E57 Q33835126-8A59C80E-4734-45D0-8F9F-7B211C18B198 Q33839267-43AC4E8F-A308-49D3-BF03-D1D8CCE812BB Q33846007-D760CEAA-CB58-4F06-9DF7-44C2E2AED845 Q33850510-240451DB-3119-497C-8EB9-8FA009C879BF Q33897693-1212DA21-F50B-488A-91BA-F9C5BAFAB12C Q34004618-45A699AD-1604-489C-8EE3-E6AC1B5DA6D1 Q34012742-A6C3B4B0-8C1A-4284-AFD8-6B9F2C49C8C1 Q34034124-E518D450-CA3F-4084-8FB1-D3EA89EC7AF4 Q34216506-22662069-4D62-4482-9D7C-605687513702 Q34255654-6786F1DB-3C43-45DC-9175-F879F6287A36 Q34347386-9AB91D38-36C7-4C73-9392-ED91B15D1F2F Q34438014-7A620E83-1A22-423D-8359-F4AE5A7B9418 Q34452007-EAB417EC-C45C-42AF-9D3B-F980EA663839 Q34476278-41BED7BE-E8AF-49F8-AB75-A412589A4A3F Q34541424-F5034611-5286-423C-AB6E-72F4E274F5ED Q34550189-50783056-6EB4-4316-A1DB-9C94154A3696 Q34572198-E48E767A-71BB-4D2D-A669-4AEF7024AB58 Q34658123-CCBC79EC-68B7-4201-A873-EC4B72C56AD5 Q35137164-8FBA4D5A-6254-42FD-A316-EF105584B62F Q35148879-25095E73-0A6F-4034-BCB8-02C25B06999B Q35224721-E8ACE331-FC06-46AE-AD5F-A44CA34E4738 Q35616090-2A10597F-6D8C-488D-9186-71EF0647641F Q35622028-AF7E64A2-89CE-4011-851E-D5D8EA6BE1FB Q35747229-DF343831-834B-48E3-8D2D-62B06C91A0B9 Q35793849-EA830997-8AD4-454C-8B33-82CD4F7E84F5

P2860

Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells.

http://www.wikidata.org/entity/Q33855405

description

1999 nî lūn-bûn

@nan

1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

1999 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

name

Rapid generation of broad T-ce ...... ion of mature dendritic cells.

@ast

Rapid generation of broad T-ce ...... ion of mature dendritic cells.

@en

type

label

Rapid generation of broad T-ce ...... ion of mature dendritic cells.

@ast

Rapid generation of broad T-ce ...... ion of mature dendritic cells.

@en

prefLabel

Rapid generation of broad T-ce ...... ion of mature dendritic cells.

@ast

Rapid generation of broad T-ce ...... ion of mature dendritic cells.

@en

P1433

Q33855405-7DB8989D-A256-4DB2-95C3-259841287475

P1476

Q33855405-B9C11F54-0B9E-4E61-BAF7-7A5002314731

P2093

Q33855405-32EF8D6E-83AF-4DFF-99A4-AD5D346D9289

Q33855405-5D124124-4DD9-4566-A68F-408C825C5E3A

Q33855405-9788DE9A-C06F-4D99-A710-951C1F08464F

Q33855405-ACD9E06C-9B28-4F9E-AD65-3ED6CB0513FA

Q33855405-BB487B32-CAB6-418D-A53A-0B11607E90E2

Q33855405-BD27E81C-B108-4EC8-8D4A-4DD6A70FA772

Q33855405-BE9A2B5F-0E88-40CC-9FC2-959D2FA69F95

Q33855405-DD8B97B3-A672-4212-8863-4A355A99D46C

Q33855405-E4BD5E6F-99BB-4479-9218-CF51ACFDC902

Q33855405-EFCB8A4B-B99C-46D2-B1A0-AA0F42D46C12

P2860

Q33855405-00FB54E7-35C7-47EE-AF80-CAE63EBE24E2

Q33855405-07EBD729-CF5C-4D19-AC5E-C6597395F5DF

Q33855405-090434F5-C8CE-467C-A362-93C8D3A4EB70

Q33855405-11CD41F9-07D0-4423-918B-B7B79B0AAC5A

Q33855405-14AD2482-D320-4820-9A8C-3B7D8C13AC20

Q33855405-1E695A0B-4E41-4C46-9915-B6F8004C8001

Q33855405-3F227763-22C4-4003-8E7C-F8F05EA8D77E

Q33855405-5691594B-FB29-490E-AE31-A27703CC89A4

Q33855405-6017A66C-6E32-4FE5-99D7-4A3FE113EC96

Q33855405-6EDC33DD-0061-4308-A107-70C9479CD3D6

P304

Q33855405-842A560B-DF15-4CE0-9063-C3E47B26727F

P31

Q33855405-FB04BD29-5750-45C9-B10B-8018700F4E03

P356

Q33855405-2697574D-BA33-45F7-ADEF-F510EF69DDBB

P407

Q33855405-624BDF61-04CB-4DE7-86D5-1372B0C362A1

P433

Q33855405-5D29247A-A9B3-46A7-9345-9566139AA7B3

P478

Q33855405-6113B898-211B-4D07-B827-706E9DBD2ACB

P50

Q33855405-4D708493-29BC-4791-A12A-E4DF1D184AF5

P577

Q33855405-F56B8E6F-52DA-4DB1-80E0-B3C6C6FF3E59

P5875

Q33855405-46DC5451-985A-4839-9D94-4DAFB299CFFD

P698

Q33855405-0505282F-03A8-4D07-AB96-C73F816F374D

P932

Q33855405-825D6A2E-6EE9-411A-918C-70459585ED50

P356

P1433

Journal of Clinical Investigation

P1476

Rapid generation of broad T-ce ...... tion of mature dendritic cells

@en

P2093

C Fossella

http://www.w3.org/2001/XMLSchema#string

D F Nixon

http://www.w3.org/2001/XMLSchema#string

H Desai

http://www.w3.org/2001/XMLSchema#string

J Krasovsky

http://www.w3.org/2001/XMLSchema#string

M Sapp

http://www.w3.org/2001/XMLSchema#string

M V Dhodapkar

http://www.w3.org/2001/XMLSchema#string

N Bhardwaj

http://www.w3.org/2001/XMLSchema#string

R M Steinman

http://www.w3.org/2001/XMLSchema#string

S M Donahoe

http://www.w3.org/2001/XMLSchema#string

V Cerundolo

http://www.w3.org/2001/XMLSchema#string

P2860

Dendritic cells and the control of immunity

Phenotypic analysis of antigen-specific T lymphocytes

Influenza virus-infected dendritic cells stimulate strong proliferative and cytolytic responses from human CD8+ T cells.

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.

Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses.

Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity

Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.

CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells

Origin, maturation and antigen presenting function of dendritic cells.

Idiotypic protein-pulsed adherent peripheral blood mononuclear cell-derived dendritic cells prime immune system in multiple myeloma.

P304

173-180

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI6909

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

104

http://www.w3.org/2001/XMLSchema#string

P50

P577

1999-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12887018

http://www.w3.org/2001/XMLSchema#string

P698

10411546

http://www.w3.org/2001/XMLSchema#string

P932

408478

http://www.w3.org/2001/XMLSchema#string